The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUk Oil & Gas Regulatory News (UKOG)

Share Price Information for Uk Oil & Gas (UKOG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.029
Bid: 0.028
Ask: 0.03
Change: 0.00 (0.00%)
Spread: 0.002 (7.143%)
Open: 0.029
High: 0.029
Low: 0.029
Prev. Close: 0.029
UKOG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results and Refinancing

8 Nov 2013 15:41

RNS Number : 6172S
Sarantel Group PLC
08 November 2013
 

For immediate release

8 November 2013

 

Sarantel Group Plc

("Sarantel" or the "Company")

Proposed Subscription of 500,000,000 A Ordinary Shares of 0.03p each

Proposed Capital Reorganisation

Proposed adoption of Investing Policy

Notice of General Meeting

Interim Results

 

The Board of Sarantel announces that it has today posted a circular to Shareholders setting out details of a proposed refinancing of the Company, a capital reorganisation and proposed adoption of an Investing Policy (the "Proposals").

 

As previously announced on 4 October 2013, the Company was informed by PricewaterhouseCoopers LLP ("PWC") that on 2 October 2013 PWC had entered into a sale agreement for the sale of Sarantel Limited's business and assets for an undisclosed sum (the "Sale"). The Sale resulted in the disposal of the Company's entire Operating Business and, as such, constituted a fundamental change of business of the Company under Rule 15 of the AIM Rules, resulting in the Company becoming an Investing Company under the AIM Rules. Furthermore, Rule 15 of the AIM Rules requires the Company to state its Investing Policy and to obtain approval from the Shareholders of that Investing Policy going forward.

 

Trading in the Ordinary Shares on AIM has been suspended since 29 May 2013 pending clarification of the financial position of the Company. The Proposals are, in the opinion of the Directors, the only realistic chance of enabling the Company's Ordinary Shares to recommence trading on AIM prior to 29 November 2013, failing which trading in the Company's Ordinary Shares on AIM would be cancelled. Assuming the Resolutions are passed to implement the Proposals, and following the publication of the interim results for the six months ended 31 March 2012 as set out in Appendix III below, it is expected that trading in the New Ordinary Shares will recommence on 26 November 2013. The Company will be then required to make an acquisition or acquisitions which constitute a reverse takeover under the AIM Rules or otherwise implement its Investing Policy to the satisfaction of the London Stock Exchange within 12 months of 4 October 2013, the date on which PWC entered into the sale agreement for the sale of Sarantel's business and assets, failing which, the Company's Ordinary Shares would then be suspended from trading on AIM. If the Company's Investing Policy has not been implemented within 18 months of the Sale the admission to trading on AIM of the Ordinary Shares would be cancelled.

 

Shareholders should note that in the event that the Proposals do not proceed for any reason including the failure of the Resolutions to be passed, the Company will be placed immediately into administration.

 

Enquiries:

 

Sarantel Group PLC

David Wither

Tel: 07974 352236

Beaumont Cornish (Nominated Adviser)

Roland Cornish / Emily Staples

Tel: 020 7628 3396

 

The full text of the document issued today setting out full details of the Proposals is set out below:

 

"Proposed Subscription of 500,000,000 A Ordinary Shares of 0.03p each

Proposed Capital Reorganisation

Proposed adoption of Investing Policy

Notice of General Meeting

 

 

1. Introduction

 

The Company announced:

On 29 May 2013 that the Board had concluded that there was insufficient probability of concluding a sale of the Operating Business and had therefore requested a suspension from trading on AIM in the Company's shares until such time as the Company's financial position could be clarified.

On 31 May 2013 that the Board had received a letter of demand from a secured creditor for the immediate repayment by Sarantel Limited of the secured HSBC Loan Facility of £2,000,000 (plus accrued interest, as at 29 May 2013, of approximately £17,000) which had been fully drawn down by Sarantel Limited. Security for the HSBC Loan facility was provided by the secured creditor, in return for which Sarantel Limited, inter alia, granted a debenture in favour of the secured creditor which contained fixed and floating charges over the assets and undertaking of Sarantel Limited, including its intellectual property portfolio on 13 June 2013 that the directors of Sarantel Limited had appointed PricewaterhouseCoopers LLP as an administrator to Sarantel Limited, the operating subsidiary of the Company.

On 4 October 2013 that the Company had been informed by PricewaterhouseCoopers LLP ("PWC") that on 2 October 2013 PWC entered into a sale agreement for the sale of Sarantel Limited's business and assets for an undisclosed sum (the "Sale"). The Sale had resulted in the disposal of the Company's entire Operating Business and, as such, constituted a fundamental change of business of the Company under Rule 15 of the AIM Rules, resulting in the Company becoming an Investing Company under the AIM Rules. The Board had been further informed that PWC did not expect to realise any further amounts from the assets in Sarantel Limited and did not expect therefore that Sarantel would receive any payment from the Sale. The Directors were accordingly considering the impact of the Sale on the financial position of Sarantel (which is not itself currently in administration) and the potential options, if any, for securing funding for Sarantel which currently had net liabilities. The suspension from trading on AIM in the Company's Ordinary Shares would continue until such time as the Company's financial position could be clarified. 

 

The purpose of this Document is to provide Shareholders with information on the Proposals, including why the Directors consider that the Proposals are in the best interests of the Company and its Shareholders as a whole and why they recommend that you vote in favour of the Resolutions to be proposed at the General Meeting, Notice of which is set out at the end of this Document. The Sale has resulted in the Company being treated as an Investing Company as it has disposed of all of its trading business. As a consequence, Rule 15 of the AIM Rules requires the Company to state its Investing Policy in this Document and to obtain approval from the Shareholders of that Investing Policy going forward. Further details of the Investing Policy are set out in paragraph 4 below.

 

Following approval of the Investing Policy by the Shareholders at the General Meeting, the Company will be required to make an acquisition or acquisitions which constitute a reverse takeover under the AIM Rules or otherwise implement its Investing Policy to the satisfaction of the London Stock Exchange within 12 months of 4 October 2013, the date on which PWC entered into a sale agreement for the sale of Sarantel's business and assets, failing which, the Company's Ordinary Shares would then be suspended from trading on AIM. If the Company's Investing Policy has not been implemented within 18 months of the Sale the admission to trading on AIM of the Ordinary Shares would be cancelled and the Directors will convene a general meeting of the Shareholders to consider whether to continue seeking investment opportunities or to wind up the Company and distribute any surplus cash back to Shareholders.

 

As you are aware, the trading in the Ordinary Shares on AIM has been suspended since 29 May 2013 pending clarification of the financial position of the Company. The Proposals are, in the opinion of the Directors, the only realistic chance of enabling the Company's Ordinary Shares to recommence trading on AIM prior to the 29 November 2013, failing which trading in the Company's Ordinary Shares on AIM would be cancelled. Assuming the Resolutions are passed to implement the Proposals, and the interim results for the six months ended 31 2012 are published, it is expected that trading in the New Ordinary Shares will commence on 26 November 2013.

 

The Directors have irrevocably undertaken to vote in favour of the Resolutions in respect of 32,059,645 Ordinary Shares, representing approximately 2.90 per cent. of the existing issued ordinary share capital of the Company.

 

Shareholders should note that in the event that the Proposals do not proceed for any reason including the failure of the Resolutions to be passed, the Company will be placed immediately into administration.

 

2. Subscription

 

Pursuant to the terms of the Subscription, the Subscribers have conditionally agreed to subscribe for 500,000,000 New A Ordinary Shares, in aggregate, at the Subscription Price, raising approximately £150,000 before expenses for the benefit of the Company. This new capital will enable the Company to settle immediate outstanding liabilities and enable the ongoing running expenses of the Company to be met.

The Subscription is conditional, inter alia, upon the passing of the Resolutions and the admission of the Subscription Shares to trading on AIM. Accordingly, the Company has convened the General Meeting, Notice of which is set out at the end of this Document.

The Subscription Shares, when issued and fully paid, will rank equally in all respects with the New A Ordinary Shares.

It is expected that Admission will become effective and dealings in the Subscription Shares will commence on or about 26 November 2013.

Following the Subscription and Admission, the Company will have 610,730,177 New Ordinary Shares in issue and admitted to trading on AIM. This will consist of 610,711,787 New A Ordinary Shares and 18,390 New B Ordinary Shares. The Subscription Shares will represent approximately 82 per cent. of the Enlarged Issued Share Capital. The Proposed Directors have subscribed for the following Subscription Shares:

 

Name

Number of Subscription Shares

Percentage of Enlarged Issued Share Capital

David Lenigas

73,333,334

12%

Donald Strang

73,333,334

12%

 

3. Background to and reasons for Capital Reorganisation

 

The Subscription Price is below the present nominal value of the Existing Ordinary Share. Company law prohibits a company from issuing shares at a discount to the nominal or par value of its shares. Therefore, in order to carry out the Subscription using the A Ordinary Shares which rank pari passu in all respects with the existing A Ordinary Shares, it is necessary to reduce the nominal value of the Company's existing A Ordinary Shares. Further as the Directors do not wish the A Ordinary Shares and B Ordinary Shares to have differing par values because whilst they constitute separate classes of shares, they rank pari passu in all respects, save for an immaterial difference specifically set out in the Company's articles of association, it is deemed necessary to reduce the nominal value of the existing B Ordinary Shares. Premium paid up on an existing Ordinary Share will, following the Capital Reorganisation, be attributed to the New Ordinary Share arising therefrom. Accordingly, the Directors, propose to effect a share reorganisation on the following basis:

(a) each of the issued A Ordinary Shares of 0.1p will be subdivided and redesignated into one A ordinary share of 0.001p each and ninety nine New Deferred Shares then every ten new A ordinary shares of 0.001p each in issue will be consolidated into one New A Ordinary Share;

(b) each of the issued B Ordinary Shares of 0.1p will be subdivided and redesignated into one B ordinary share of 0.001p each and ninety nine New Deferred Shares then every ten new B ordinary shares of 0.001p each in issue will be consolidated into one New B Ordinary Share; and

(c) each of the issued Deferred Shares will be subdivided and redesignated into one hundred New Deferred Shares.

The rights attaching to the New A Ordinary Shares and New B Ordinary Shares will, apart from the change in nominal value and the entitlement of Shareholders in respect of a return of capital arising from them, be identical in all respects to those of the existing A Ordinary Shares and the existing B Ordinary Shares, respectively.

The New Deferred Shares will have the same rights as the existing Deferred Shares. That is the New Deferred Shares will have no voting rights and will not carry any entitlement to attend general meetings of the Company; nor will they be admitted to AIM or any other market. They will carry only a priority right to participate in any return of capital to the extent of £1 in aggregate over the class. In addition, they will carry only a priority right to participate in any dividend or other distribution to the extent of £1 in aggregate over the class. In each case a payment to any one holder of New Deferred Shares shall satisfy the payment required. The Company will be authorised at any time to effect a transfer of the New Deferred Shares without reference to the holders thereof and for no consideration. Accordingly the New Deferred Shares will (like the existing Deferred Shares), for all practical purposes, be valueless and it is the Board's intention, at an appropriate time, to have the New Deferred Shares cancelled, whether through an application to the Companies Court or otherwise.

Existing share certificates will continue to be valid following the Capital Reorganisation and no certificates will be issued in respect of the New Deferred Shares. No fractional entitlement arising in connection with the Capital Reorganisation will be allotted. 

The Notice set out at the end of this Document contains resolutions to give effect to the proposed Capital Reorganisation and the Subscription which are conditional, amongst other matters, on the passing of Resolutions.

4. Proposed Investing Policy

 

The Company's proposed Investing Policy, which is subject to Shareholder approval at the General Meeting, is set out below:

 

Investing Policy

The Company's proposed Investing Policy is to invest in and/or acquire companies and/or projects within the natural resources sector with potential for growth. The Company will also consider opportunities in other sectors as they arise if the New Board considers there is an opportunity to generate potential value for Shareholders. The geographical focus will primarily be in regions in the world that the New Board considers valuable opportunities exist and potential returns can be achieved.

Where appropriate, the New Board may seek to invest in businesses where it may influence the business at a board level, add their expertise to the management of the business, and utilise their industry relationships and access to finance.

The Company's interests in a proposed investment and/or acquisition may range from a minority position to full ownership and may comprise one investment or multiple investments. The proposed investments may be in either quoted or unquoted companies; be made by direct acquisitions or farm-ins; and may be in companies, partnerships, earn-in joint ventures, debt or other loan structures, joint ventures or direct or indirect interests in assets or projects. The New Board may focus on investments where intrinsic value may be achieved from the restructuring of investments or merger of complementarybusinesses.

The New Board expects that investments will typically be held for the medium to long term, although short term disposal of assets cannot be ruled out if there is an opportunity to generate a potentially attractive return for Shareholders. The New Board will place no minimum or maximum limit on the length of time that any investment may be held. The Company may be both an active and a passive investor depending on the nature of the individual investment.

There is no limit on the number of projects into which the Company may invest, and the Company's financial resources may be invested in a number of propositions or in just one investment, which may be deemed to be a reverse takeover under the AIM Rules. The New Board intend to mitigate risk by appropriate due diligence and transaction analysis. Any transaction constituting a reverse takeover under the AIM Rules will also require Shareholder approval. The New Board considers that as investments are made, and new promising investment opportunities arise, further funding of the Company may also be required.

Where the Company builds a portfolio of related assets it is possible that there may be cross holdings between such assets. The Company does not currently intend to fund any investments with debt or other borrowings but may do so if appropriate. Investments in early stage assets are expected to be mainly in the form of equity, with debt potentially being raised later to fund the development of such assets. Investments in later stage assets are more likely to include an element of debt to equity gearing. The New Board may also offer New Ordinary Shares by way of consideration as well as cash, thereby helping to preserve the Company's cash for working capital and as a reserve against unforeseen contingencies including, for example, delays in collecting accounts receivable, unexpected changes in the economic environment and operational problems.

Investments may be made in all types of assets and there will be no investment restrictions on the type of investment that the Company might make nor the type of opportunity that may be considered.

The Company may consider possible opportunities anywhere in the world.

The New Board will conduct initial due diligence appraisals of potential business or projects and, where they believe further investigation is warranted, intend to appoint appropriately qualified persons to assist. The New Board believes its expertise will enable it to determine quickly which opportunities could be viable and so progress quickly to formal due diligence. The Company will not have a separate investment manager.

Following on from adopting an Investing Policy, the Company will be required to make an acquisition or acquisitions which constitute a reverse takeover under the AIM Rules or otherwise implement its Investing Policy within 12 months of 4 October 2013, failing which the Ordinary Shares would then be suspended from trading on AIM. If the Investing Policy has not been implemented within 18 months of the General Meeting the admission to trading on AIM of the Ordinary Shares would be cancelled and the New Board will convene a general meeting of the Shareholders to consider whether to continue seeking investment opportunities or to wind up the Company and distribute any surplus cash back to Shareholders.

 

The initial focus of the Company will be the achievement of capital growth for Shareholders and therefore the Company will only consider the payment of dividends as and when it is appropriate to do so. As such, it is not possible at this stage to give an indication of the likely level or timing of any future dividends. To the extent that any dividends are paid they will be paid in accordance with any applicable laws and the regulations to which the Company is subject. The amount of the dividends paid to Shareholders will fluctuate according to the levels of profits earned by the Company and will be dependent on sufficient distributable reserves being available to the Company.

 

5. New Board

 

On and subject to Admission, Oliver Leisten, Philip David, Nicola Malyon and myself will resign from office and Messrs David Lenigas and Donald Strang will be appointed to the Board. Following Admission, the New Board will consist of: David Lenigas as Non-executive chairman, Donald Strang as Non-executive director and David Wither as Non-executive director. Further information on David Lenigas and Donald Strang is set out below:

 

David Lenigas (proposed Non-executive Chairman), aged 52

 

Mr. Lenigas has extensive experience operating in global public markets having served in a senior executive capacity on many public company boards. He is currently the Executive Chairman of Rare Earth Minerals Plc, Leni Gas and Oil Plc, AfriAg Plc, Solo Oil Plc, Inspirit Energy Holdings Plc and various other AIM companies. He has also served as Executive Chairman of London listed Lonrho plc for six years up to September 2012 and was responsible for Lonrho plc's expansion into over 20 countries in Africa in sectors covering agriculture, infrastructure, hotels, IT and aviation.

 

Donald Strang (proposed Non-executive Director), aged 45

 

Mr. Strang is a member of the Australian Institute of Chartered Accountants and has been in business over 20 years, holding senior financial and management positions in both publicly listed and private enterprises in Australia, Europe and Africa. Mr. Strang has considerable corporate and international expertise and over the past decade has focused on mining and exploration activities in the oil and gas and natural resources sectors. He is currently finance director for AfriAg Plc, Rare Earth Minerals Plc, Polemos Plc, Doriemus Plc and Stellar Resources Plc.

Further information required to be disclosed under the AIM Rules in respect of the Proposed Directors will be notified via an RIS prior to or on their appointment as Directors.

 

The principal terms of appointment for each Proposed Director with effect from Admission are fees of £2,000 per calendar month and terminable by 12 months' prior written notice by the Company.

 

6. Financial Effects of the Sale and the Subscription

 

The Sale, as referred to above, by PWC of the Group's entire Operating Business for an undisclosed sum by PWC together with the fact that the Board has been informed by PWC that there will be no proceeds accruing to Sarantel from either the Sale or from the possible disposal of any other assets of Sarantel Limited is effectively the disposal of Sarantel Limited for no consideration to Sarantel.

 

As at 31 March 2013, the unaudited gross assets and net liabilities of Sarantel Limited were £3,284,764 and (£27,650,109) respectively and the liabilities were £30,940,943 including a loan due to HSBC of £2,000,000 and an intercompany balance due to Sarantel of £27,826,665. Whilst PWC has not disclosed details to the Company, it is the Board's understanding that these liabilities have either been discharged under the Administration or will remain with Sarantel Limited. The Board has been informed that the HSBC Loan Facility will be repaid by a secured creditor of Sarantel Limited by the end of the year. Accordingly, the Company's liabilities, as far as the Board is aware, as at the date of this document (taking into account arrangements with certain creditors) are approximately £87,000 (including VAT).

 

These liabilities will be met by the proceeds of the Subscription with the remainder to provide working capital to support the Company's Investing Policy. To the extent that further funds are required to be raised on any acquisition or investment, the new Board will make appropriate arrangements.

 

For the six months ended 31 March 2013 and the year ended 30 September 2012, Sarantel Limited reported losses before taxation of £928,101(unaudited) and £1,457,098 (audited) respectively.

 

7. Share Options

 

Subject to the passing of the Resolutions, the Company intends to grant options to subscribe for New Ordinary Shares from time to time to incentivise directors, employees and consultants at the discretion of the New Board. Options granted to subscribe for New Ordinary Shares in this manner will not exceed 10 per cent. of the Company's issued share capital from time to time without the prior approval of the Shareholders.

 

The Company also intends to adopt an incentive plan under which it may award New Ordinary Shares for no cost to directors, employees and consultants. New Ordinary Shares under this plan will not exceed 10 per cent. of the Company's issued share capital from time to time without the prior approval of the Shareholders.

 

The New Board will review the Company's existing share option schemes and share incentive plans following Admission to determine whether they are appropriate or if new schemes should be established. 

 

8. General Meeting

 

The Proposals are conditional upon the passing of the Resolutions at the General Meeting as described below. You will find set out at the end of this Document, the Notice convening the General Meeting to be held at 200 Strand, London WC2R 1DJ at 10.00 a.m. on 25 November 2013, at which the following Resolutions will be proposed.

 

 

Resolution 1:

 

Resolution 1 seeks approval for the Capital Reorganisation.

 

Resolution 2:

 

Resolution 2 seeks approval for the adoption of the Investing Policy.

 

Resolution 3:

 

This resolution provides the Directors with the general authority to allot and issue the Subscription Shares and New A Ordinary Shares up to the aggregate nominal amount of £200,000.

 

Resolution 4:

 

This resolution seeks to dis-apply statutory pre-emption rights up to the aggregate nominal amount of £200,000 in respect of the allotment of the Subscription Shares and New A Ordinary Shares.

 

Resolution 5:

 

This resolution seeks to amend the Company's articles of association, as appropriate, to reflect the Capital Reorganisation and authorise the Directors to change the name of the Company by Board resolution as permitted by the Companies Act 2006.

 

9. Risk Factors

 

Your attention is drawn to the Risk Factors set out in Part II and to the section entitled "Forward Looking Statements" on page 2 of this Document. Any investment by the Company as part of the Proposed Investing Policy will carry a high degree of risk. Shareholders should carefully consider all the "Risk Factors" in Part II of this Document. These risks and uncertainties are not the only ones facing the Company and additional risks and uncertainties not presently known or which are currently deemed immaterial may also have a material adverse effect on the Company's business, results of operations or financial condition.

If any or a combination of the risks materialise, the Company's business, financial condition, operational performance and share price could be materially and adversely affected to the detriment of the Company and the Shareholders.

10. Action to be taken by Shareholders

 

A Form of Proxy for use in connection with the General Meeting accompanies this Document. The Form of Proxy should be completed in accordance with the instructions printed thereon and returned to the Company's registrars, Computershare Investor Services PLC, The Pavilions, Bridgwater Road, Bristol, BS99 6ZY as soon as possible, but in any event so as to be received by 10.00 a.m. on 23 November 2013.

 

The completion and return of a Form of Proxy will not preclude Shareholders from attending the General Meeting and voting in person, should they so wish. Shareholders who hold their Ordinary Shares through a nominee should instruct the nominee to submit the Form of Proxy on their behalf.

 

CREST members who wish to appoint a proxy or proxies through the CREST electronic proxy appointment service may do so for the General Meeting and any adjournment(s) thereof by using the procedures described in the CREST Manual. CREST personal members or other CREST sponsored members and those CREST members who have appointed (a) voting service provider(s) should refer to their CREST sponsor or voting service provider(s), who are able to take the appropriate action on their behalf.

 

 

11. Board Recommendation

 

Shareholders should note that in the event that the Proposals do not proceed for any reason, including the failure of the Resolutions to be passed, the Company will immediately be placed into administration.

 

The Directors consider the approval of the Proposals to be in the best interests of the Company and the Shareholders as a whole. Accordingly, the Directors recommend that Shareholders vote in favour of the Resolutions to be proposed at the General Meeting as they intend to do so in respect of their aggregate beneficial holding of 32,059,645 Ordinary Shares, representing approximately 2.9 per cent. of the issued share capital of the Company as at the date of this Document.

 

 

Yours faithfully,

 

 

Geoff Shingles

Chairman

 

PART II

Shareholders should carefully consider all of the information in this Document including the risks below. The Board have identified these risks as material risks, but additional risks and uncertainties not presently known to the Board, or that the Board consider immaterial, may also adversely affect the Company. If any or a combination of the following risks materialise, the Company's business, financial condition and/or performance could be materially adversely affected. In any such case the market price of the Ordinary Shares could decline.

 

The following risk factors should not be considered in any order of priority. The Company's future performance might be affected by changes in market conditions and legal, regulatory and tax requirements.

 

RISKS RELATING TO THE COMPANY'S INVESTING POLICY

 

Limited operating history as an Investing Company

 

The Company will only commence pursuing its Investing Policy following approval of the Resolutions. There can be no assurance that the Company will be successful or it will meet the objectives of its Investing Policy. There is, therefore, no basis on which to evaluate the Company's ability to achieve its objective, implement its Investing Policy and provide a satisfactory investment return. Any failure in achieving its Investing Policy or in managing its financial controls, reporting systems or procedures could have a material adverse effect on the Company's results of operations, financial condition and prospects.

 

Identifying a suitable target

 

The Company will be dependent upon the ability of the New Board to identify suitable investment opportunities and to implement the Investing Policy. As at the date hereof, the New Board has not identified any investment opportunities which they have resolved to pursue. If the Board does not identify an opportunity that corresponds to the Investing Policy for creating value, then the Company may not be able to invest its cash in a manner which accomplishes its objectives. There is no guarantee that the Company will be able to acquire an identified opportunity at an appropriate price, or at all, as a consequence of which resources might have been expended fruitlessly on investigative work and due diligence.

 

Change in Investing Policy

 

The Investing Policy may be modified and altered from time to time, but only after obtaining Shareholder approval, so it is possible that the approaches adopted to achieve the Company's investment objectives in the future may be different from those presently expected to be used and disclosed in this Document.

 

Market conditions

 

Market conditions may have a negative impact on the Company's ability to execute investments in suitable assets which generate acceptable returns. There is no guarantee that the Company will be successful in sourcing suitable assets.

 

The Company can give no assurance as to how long it will take it to invest any or all of the Subscription proceeds, if at all, and the longer the period the greater the likely impact on the Company's performance and financial condition.

 

Costs associated with potential investments

 

The Company expects to incur certain third party costs associated with the sourcing of suitable investments. The Company can give no assurance as to the level of such costs, and given that there can be no guarantee that negotiations to acquire any given investment will be successful, the greater the number of deals that do not reach completion, the greater the likely impact of such costs on the Company's performance, financial condition and business prospects.

 

Ownership risks

 

Under the Investing Policy, the Company has the ability to enter into a variety of investment structures, including joint ventures, acquisition of controlling interests or acquisition of minority interests.

 

In the event the Company acquires a 100 per cent. interest in a particular asset or entity, or makes a single investment in an entity, the resulting concentration of risk may result in a total or partial loss on its investment and have a material adverse effect on the Company's performance.

 

In the event the Company acquires less than a 100 per cent. interest in a particular asset or entity, the

remaining ownership interest will be held by third parties and the subsequent management and control of such an asset or entity may entail risks associated with multiple owners and decision-makers. Any such investment also involves the risk that third party owners might become insolvent or fail to fund their share of any capital contribution which might be required. In addition, such third parties may have economic or other interests which are inconsistent with the Company's interests, or they may obstruct the Company's plans, or they may propose alternative plans. If such third parties are in a position to take or influence actions contrary to the Company's interests and plans, this may affect the ability of the Company to implement its strategies.

 

In addition, there is a risk of disputes between the Company and third parties who have an interest in the asset or entity in question. Any litigation or arbitration resulting from any such disputes may increase the Company's expenses and distract the New Board from focusing its time to fulfil the Investing Policy. The Company may also, in certain circumstances, be liable for the actions of such third parties.

 

Due diligence process

 

The Company intends to conduct such due diligence as it deems reasonably practicable and appropriate, based on the facts and circumstances applicable to each potential project, before making an investment. The objective of the due diligence process will be to identify material issues which might affect an investment decision. When conducting due diligence and making an assessment regarding an investment, the Company will be required to rely on resources available to it, including, in the main, public information and, in some circumstances, third party investigations. As a result, there can be no assurance that the due diligence undertaken with respect to any potential project will reveal or highlight all relevant facts that may be necessary or helpful in evaluating such project.

 

Valuation error

 

The Company may miscalculate the realisable value of an investment in a project. A lack of reliable information, errors in assumptions or forecasts and/or inability to successfully implement an investment, among other factors, could all result in the project having a lower realisable value than anticipated. If the Company is not able to realise an investment at its anticipated levels of profitability, projected investment returns could be adversely affected.

 

Financing

 

Implementation of the Investing Policy may require significant capital investment. The only sources of financing currently available to the Company is the proceeds from the subscription and any potential future issue of additional equity capital or shareholder loans. The Company's ability to raise further funds will depend on the success of existing and acquired investments. The Company may not be successful in procuring the requisite funds on terms which are acceptable to it (or at all) and, if such funding is unavailable, the Company may be required to reduce the scope of its investments or anticipated expansion. Further, Shareholders' holdings of Ordinary Shares may be materially diluted if debt financing is not available."

 

 

Appendix I

 

EXPECTED TIMETABLE OF PRINCIPAL EVENTS

 

Despatch of this Document

8 November 2013

Latest time and date for receipt of Forms of Proxy

10.00 a.m. on 23 November 2013

General Meeting

10.00 a.m. on 25 November 2013

Record Date for the Capital Reorganisation

6.00 p.m. on 25 November 2013

Re-commencement of trading on AIM

26 November 2013

Admission effective and trading expected to commence in the Subscription Shares and the New Ordinary Shares

26 November 2013

CREST accounts credited with Subscription Shares and New Ordinary Shares

26 November 2013

Share certificates expected in respect of Subscription Shares to be despatched no later than (where applicable)

9 December 2013

 

 

 

Notes

 

1. References to time in this Document are to London time unless otherwise stated.

 

2. Unless expressly stated otherwise, all future times and dates in this Document are indicative only and may be subject to change.

 

3. All events in the above timetable following the General Meeting are conditional upon approval by the Shareholders of the Resolutions.

 

 

 

SUBSCRIPTION STATISTICS

 

Subscription Price

0.03p

Number of Subscription Shares being issued by the Company pursuant to the Subscription

500,000,000

Number of New Ordinary Shares in issue immediately before the issue of the Subscription Shares*

110,730,177

Number of New Ordinary Shares in issue immediately following the issue of the Subscription*

610,730,177

Percentage of Enlarged Issued Share Capital represented by the Subscription Shares*

82%

Amount, before expenses, being raised in the Subscription

£150,000

Market capitalisation at the Subscription Price immediately following Admission

£183,219

 

 

 

 

*assuming no shares are issued pursuant to the exercise of any Warrants, Options or otherwise

 

Appendix II

DEFINITIONS

The following definitions apply throughout this announcement unless the context requires otherwise:

 

"A Ordinary Shares"

the A ordinary shares of 0.1p each in the capital of the Company;

"Admission"

admission of the Subscription Shares to trading on AIM becoming effective in accordance with the AIM Rules;

 

"AIM"

AIM, a market of that name operated by the London Stock Exchange;

 

"AIM Rules"

the AIM Rules for Companies, incorporating guidance notes, published by the London Stock Exchange governing, inter alia, admission to AIM and the continuing obligations of companies admitted to trading on AIM, as amended or reissued from time to time;

 

"B Ordinary Shares"

the B ordinary shares of 0.1p each in the capital of the Company;

 

"Capital Reorganisation"

together, the Subdivision and the Consolidation;

 

 

 

"Company" or "Sarantel"

Sarantel Group Plc (incorporated and registered in England and Wales with registered number 5299925) whose registered office is at Unit 2 Wendel Point, Ryle Drive, Park Farm South, Wellingborough NN8 6BA;

 

"Consolidation"

the consolidation of every ten Subdivided Ordinary Shares into one ordinary share of 0.01p each (being an A ordinary share or B ordinary share dependent upon the designation of the Subdivided Ordinary Shares);

 

"CREST"

 

the relevant system (as defined in the CREST Regulations) for the paperless settlement of share transfers and the holding of shares in uncertificated form operated by Euroclear;

 

"CREST Regulations"

 

the Uncertificated Securities Regulations 2001 (SI 2001 No. 01/3755), as amended;

 

"Deferred Shares"

the existing 10,487,624,769 deferred shares of 0.1p each in the capital of the Company;

 

"Directors" or the "Board"

the directors of the Company whose names are set out on page 9 of this Document;

 

"Document"

this document, being a circular to Shareholders and the accompanying Notice;

 

"Enlarged Issued Share Capital"

the issued New Ordinary Shares immediately following Admission;

 

 

"Existing Ordinary Shares"

the 1,107,301,771 Ordinary Shares in issue at the date of this Document;

 

 

"Form of Proxy"

the form of proxy accompanying this Document for use by the Shareholders at the General Meeting;

 

"General Meeting" or "GM"

the general meeting of the Company, convened by the Notice, to be held at 10.00 a.m. at 200 Strand, London WC2R 1DJ on 25 November 2013, or any adjournment thereof;

 

"Group"

the Company and its subsidiaries as at the date of this Document;

 

"HSBC Loan Facility"

the £2 million secured loan facility with a two year term and interest rate of 3 per cent. per annum over the HSBC Bank plc's sterling base rate on 28 February 2012 provided by HSBC Bank plc in favour of Sarantel Limited;

 

"Investing Company"

has the meaning given in the glossary to the AIM Rules;

 

"Investing Policy"

the proposed investing policy of the Company, to be pursued by the Company following Admission subject to Shareholder approval at the GM, further details of which are set out in paragraph 4 of Part I of this Document;

 

"London Stock Exchange"

 

London Stock Exchange plc;

"New A Ordinary Shares"

the new A ordinary shares of 0.01p each in the capital of the Company arising from the Capital Reorganisation;

 

"New Board"

David Lenigas, Donald Strang and David Wither;

 

"New B Ordinary Shares"

the new B ordinary shares 0.01p each in the capital of the Company arising from the Capital Reorganisation;

 

"New Deferred Shares"

the deferred shares of 0.001p each arising from the Capital Reorganisation;

 

"New Ordinary Shares"

together the New A Ordinary Shares and the New B Ordinary Shares;

 

"Notice"

 

the notice convening the General Meeting which is set out at the end of this Document;

 

"Operating Business"

Sarantel Limited and its wholly owned subsidiaries Sarantel Asia and Sarantel USA;

 

"Options"

the outstanding options to subscribe for Ordinary Shares in the capital of the Company at the date of this Document;

 

"Ordinary Shares"

together the A Ordinary Shares and the B Ordinary Shares;

 

"Proposals"

together the Capital Reorganisation, the proposed Subscription and the adoption of the proposed Investing Policy;

 

"Proposed Directors"

David Lenigas and Donald Strang;

 

"Resolutions"

the resolutions set out in the Notice;

 

"RIS"

Regulatory Information Service;

 

"Sarantel Asia"

Sarantel Asia Pacific Pte. Ltd;

 

"Sarantel Limited"

the wholly owned subsidiary of the Company incorporated and registered in England and Wales with company number 03960217;

 

"Sarantel USA"

Sarantel USA Inc, a wholly owned subsidiary of Sarantel Limited;

 

"Shareholders"

holders of Ordinary Shares;

 

"Sterling" or "£"

the lawful currency of the UK;

 

"Subdivided Ordinary Shares"

the ordinary shares of 0.001p each (being an A ordinary share or B ordinary share dependent upon the designation of the ordinary share) following the Subdivision;

 

"Subdivision"

the proposed subdivision of each Existing Ordinary Share into one ordinary share of 0.001p each (being an A ordinary share or B ordinary share dependent upon the designation of the Existing Ordinary Share) and ninety nine deferred shares of 0.001p each in the capital of the Company, and the proposed subdivision of each Deferred Share into one hundred deferred shares of 0.001p each in the capital of the Company;

 

"Subscribers"

the subscribers for New A Ordinary Shares pursuant to the terms of the Subscription;

 

"Subscription"

the subscription by the Subscribers for the Subscription Shares as described in Part I of this Document;

 

"Subscription Price"

0.03p per Subscription Share;

 

"Subscription Shares"

500,000,000 New A Ordinary Shares;

 

"UK" or "United Kingdom"

 

the United Kingdom of Great Britain and Northern Ireland; and

"Warrants"

the outstanding warrants to subscribe for Ordinary Shares as at the date of this Document.

 Appendix III

 

Interim results for the six months to 31 March 2013 

Sarantel Group PLC, (AIM: SLG, "Sarantel" or the Group), announces unaudited interim results for the six month period ended 31 March 2013.

Following the release of the Group's audited results for the year ended 30 September 2012, on 14 January 2013, the Board pursued various options to raise additional funding for the Group, including the disposal of the operating business to a third party, strategic investment and an AIM fundraise.

 

The Board's efforts to secure funding for the continuing operations of the Group were unsuccessful and, as announced on 13 June 2013, the Group's operating subsidiary, Sarantel Ltd, was placed into administration with PricewaterhouseCoopers LLP (PwC) appointed as administrator. PwC subsequently secured a buyer for the operating subsidiary however, which was announced on 4 October 2013.

 

Interim Results

 

In the six months to 31 March 2013, Group revenues were £1.5m (H1 2012: £0.9m). Production revenues increased by 85% after a large order was accelerated by a major customer.

 

Gross margins of 56% (H1 2012: 28%) reflect the increase in high margin military product sales.

 

The operating costs for the period were £1.6m (H1 2012: £2.0m). 

 

The Group's loss before depreciation, interest and tax was £0.7m (H1 2012: £1.5m).

 

Operating cash outflow was £0.6m (H1 2012: £1.3m), reflecting improved margins and cost control.

The Group's cash was £0.1m and the £2.0m from the HSBC Loan Facility has been fully utilised to date.

 

UNAUDITED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

FOR THE SIX MONTHS ENDED 31 MARCH 2013

 

Note

Six months to 31 March

 2013

Six months to31 March

 2012

12 months to

30 September 2012

£'000

£'000

£'000

Revenue

2

1,490

888

2,967

 Cost of sales

651

635

1,649

Gross profit

839

253

1,318

Research and development costs

584

665

1,300

Selling and distribution costs

264

283

564

Administration costs

911

1,042

1,906

Total operating costs

1,759

1,990

3,770

Operating loss

(920)

(1,737)

(2,452)

Operating loss before depreciation and amortisation

(722)

(1,513)

(2,032)

Depreciation and amortisation

(198)

(224)

(420)

Finance and other income

0

5

5

Finance and other costs

(25)

(6)

(38)

Loss before tax

(945)

(1,738)

(2,485)

Tax

3

80

125

199

Loss for the period

(865)

(1,613)

(2,286)

Other comprehensive income

-

-

-

Total comprehensive loss for the period

(865)

(1,613)

(2,286)

 

Basic and diluted loss per share

4

(0.1)p

(0.2)p

(0.3)p

 

The activities of the Group's wholly owned subsidiary are classed as non-continuing.

 

UNAUDITED CONSOLIDATED BALANCE SHEET

AS AT 31 MARCH 2013

 

 

 

Note

As at

31 March

 2013

As at31 March

 2012

As at

30 September 2012

£'000

£'000

£'000

Assets

Non-current assets

Intangible assets

1,787

1,684

1,730

Property, plant and equipment

124

209

168

Total non-current assets

1,911

1,893

1,898

Current assets

Inventories

471

545

602

Trade and other receivables

783

580

767

Current tax

80

279

188

Cash and cash equivalents

93

262

111

Total current assets

1,427

1,666

1,668

Total assets

3,338

3,559

3,566

Current liabilities

Trade and other payables

818

1,124

1,004

Amounts due under invoice financing facility

342

108

336

Total current liabilities

1,160

1,232

1,340

 

Non-current liabilities

Amounts due under loan agreements

2,000

700

1,200

Other payables

-

2

1

Total liabilities

3,160

1,934

2,541

Equity

Share capital

5,6

11,318

11,318

11,318

Share premium

18,969

18,969

18,969

Share scheme reserve

866

775

848

Warrant reserve

76

76

76

Merger reserve

13,390

13,390

13,390

Retained loss

(44,441)

(42,903)

(43,576)

Total equity

178

1,625

1,025

Total liabilities and equity

3,338

3,559

3,566

 

UNAUDITED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

FOR THE SIX MONTHS TO 31 MARCH 2013

 

Share capital

Share premium

Share scheme reserve

Warrant reserve

Merger reserve

Retained earnings

Total

 equity

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

For the six months to

31 March 2013

At 1 October 2012

11,318

18,969

848

 

76

13,390

(43,576)

1,025

Loss after tax

-

-

-

-

-

(865)

(865)

Total comprehensive income for the period

-

-

-

-

-

(865)

(865)

Share based payments

-

-

18

-

-

-

18

Transactions with owners

-

-

18

-

-

-

18

At 31 March 2013

11,318

18,969

866

76

13,390

(44,441)

178

For the six months to

31 March 2012

At 1 October 2011

11,318

18,969

728

 

76

13,390

(41,290)

3,191

Loss after tax

-

-

-

-

-

(1,613)

(1,613)

Total comprehensive income for the period

-

-

-

-

-

(1,613)

(1,613)

Share based payments

-

-

47

-

-

-

47

Transactions with owners

-

-

47

-

-

-

47

At 31 March 2012

11,318

18,969

775

76

13,390

(42,903)

1,625

For the 12 months to

30 September 2012

At 1 October 2011

11,318

18,969

728

76

13,390

(41,290)

3,191

Loss after tax

-

-

-

-

-

(2,286)

(2,286)

Total comprehensive income for year

-

-

-

-

-

(2,286)

(2,286)

Share based payments

-

-

120

-

-

-

120

Transactions with owners

1,529

1,735

120

-

-

-

120

At 30 September 2012

11,318

18,969

848

76

13,390

(43,576)

1,025

 

UNAUDITED CONSOLIDATED CASH FLOW STATEMENT

FOR THE SIX MONTHS ENDED 31 MARCH 2013

 

Six months to 31 March

 2013

Six months to 31 March

 2012

12 months to 30 September

 2012

£'000

£'000

£'000

Operating activities

Loss before tax

(945)

(1,738)

(2,485)

Adjustments for non-cash items:

Depreciation and amortisation

163

199

390

Depreciation absorbed to cost of sales

35

25

30

Investment revenue

-

(5)

(5)

Finance lease interest

32

6

30

Share based payment

18

47

120

Decrease/(increase) in inventories

132

(199)

(256)

(Increase)/decrease in trade and other receivables

(16)

104

(83)

(Decrease)/increase in trade and other payables

(186)

292

172

Taxation received

187

-

165

Net cash outflow from operating activities

(580)

(1,269)

(1,922)

Investing activities

Interest received and similar income

-

5

5

Payments to acquire intangible assets

(198)

(179)

(362)

Payments to acquire property, plant and equipment

(12)

(27)

(45)

Net cash used in investing activities

(210)

(201)

(402)

Cash outflow before financing

(790)

(1,470)

(2,324)

Financing activities

Finance lease interest paid

(33)

(6)

(29)

Loans received

800

700

1,200

Capital element of finance lease rentals

(1)

(14)

(15)

Net cash inflow from financing activities

766

680

1,155

Net increase/(decrease) in cash and cash equivalents

(24)

(790)

(1,169)

Cash and cash equivalents at start of period

(225)

944

944

Cash and cash equivalents at end of period

(249)

154

(225)

 

Analysis

 

Cash and cash equivalents

93

262

111

Amounts due under invoice financing facility

(342)

(108)

(336)

Net cash and cash equivalents

(249)

154

(225)

 

NOTES TO THE UNAUDITED INTERIM FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED 31 MARCH 2013

1 Basis of preparation

These unaudited condensed consolidated interim financial statements of Sarantel Group PLC are for the six months ended 31 March 2013. They do not include all of the information required for full annual financial statements, and should be read in conjunction with the consolidated financial statements of the Group for the year ended 30 September 2012. The financial information for the year ended 30 September 2012 set out in these interim consolidated financial statements does not constitute statutory accounts as defined in Section 434 of the Companies Act 2006. The Group's statutory financial statements for the year ended 30 September 2012 have been filed with the Registrar of Companies. The auditor's report on those financial statements was unqualified and did not contain a statement under section 498 (2) or (3) of the Companies Act 2006.

These interim consolidated financial statements have been prepared on the basis of the Group's accounting policies. These are set out in its Annual Report and Accounts for the year ended 30 September 2012 which is available on the Group's website (www.sarantel.com). 

2 Revenue

Six months to

31 March2013

Six months to

31 March2012

12 months to

30 September 2012

Unaudited

Unaudited

Audited

£'000

£'000

£'000

Sales of antennas

1,447

781

2,814

Sales of consumables

43

86

124

Sale of Non-Recurring Engineering services (NRE)

0

21

29

Total revenue

1,490

888

2,967

 

All revenue originates from the UK.

3 Tax

Six months to 31 March

 2013

Six months to 31 March

 2012

12 months to 30 September

 2012

£'000

£'000

£'000

UK corporation tax based on the results for six months to 31 March 2013

(80)

(113)

(188)

Adjustment in respect of prior year

-

(12)

(11)

Total tax credit

(80)

(125)

(199)

The taxation credit arises in respect of research and development expenditure and is subject to agreement with H M Revenue and Customs.

 

A deferred tax asset, calculated using a tax rate of 24%, amounting to approximately £8.1m arising from taxable trading losses has not been recognised on the grounds that, at the current time, there is insufficient evidence that the asset will be recoverable in the foreseeable future.

4 Loss per share

The calculation of basic loss per share is based on the loss attributable to ordinary shareholders divided by the weighted average number of shares in issue during the period.

 

Six Months to 31 March

 2013

Six Months to 31 March

 2012

12 Months to 30 September

 2012

£'000

£'000

£'000

Loss for the period

(865)

(1,613)

(2,286)

Weighted average number of shares (thousands)

830,476

830,476

830,476

Basic and diluted loss per share*

(0.1)p

(0.2)p

(0.3)p

* The effect of options and warrants are anti-dilutive.

5 Share capital

As at 31 March

2013

As at 31 March

2013

As at 31 March

2012

As at 31 March

2012

 

As at 30 September

2012

 

As at 30 September 2012

Number

£'000

Number

£'000

Number

£'000

Allotted, called-up and fully paid:

 

A ordinary shares of £0.001 each

 

829,439,991

829

829,439,991

829

829,439,991

829

B ordinary shares of £0.001 each

 

1,036,340

1

1,036,340

1

1,036,340

1

Deferred shares of £0.001 each

 

10,487,624,769

10,488

10,487,624,769

10,488

10,487,624,769

10,488

11,318,101,100

11,318

11,318,101,100

11,318

11,318,101,100

11,318

6 Share options

As at 31

March

2013

As at 31

March

2013

As at 31

March

2012

As at 31

March

2012

 

As at 30 September

2012

 

As at 30 September 2012

Number

Weighted average exercise price (p)

Number

Weighted average exercise price (p)

Number

Weighted average exercise price (p)

 

Number of share options at beginning of period

85,715,130

0.8

85,715,130

0.8

85,715,130

0.8

Options granted during the period

-

-

-

-

-

-

Options lapsed and surrendered

-

-

-

-

(2,745,085)

1.0

Balance at end of the period

85,715,130

0.8

85,715,130

0.8

82,970,045

0.6

 

A copy of this announcement is available from the Group's website, www.sarantel.com

ENDS

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR EASFPEDSDFFF
Date   Source Headline
3rd May 20244:28 pmRNSNotice of Annual General Meeting
3rd May 20247:00 amRNSEmployee Benefit Trust Share Subscription
2nd May 20247:00 amRNSLoan Reduction Update
1st May 20247:00 amRNSLoxley Gas Project Update
19th Apr 202411:59 amRNSLoan Reduction via Equity Share Subscription
2nd Apr 20247:00 amRNSAnnual Report for the year ended 30 September 2023
27th Mar 20247:00 amRNSLoxley Gas Project Update
19th Mar 20245:00 pmRNSBroadford Bridge Planning Update
13th Mar 20249:29 amRNSLoan Reduction via Equity Share Subscription
5th Mar 20243:28 pmRNSResult of Reconvened General Meeting
1st Mar 20247:00 amRNSRevised Timetable for Capital Restructuring
23rd Feb 20241:01 pmRNSNotice of General Meeting Resumption
22nd Feb 20244:37 pmRNSEmployee Benefit Trust Share Subscription
16th Feb 20241:54 pmRNSGeneral Meeting Adjournment
2nd Feb 20242:08 pmRNSPinarova-1 Testing Operations Update
1st Feb 20241:53 pmRNSProposed Capital Reorganisation
23rd Jan 20243:48 pmRNSLoan Balance Reduction via Equity Share Issue
23rd Jan 20247:00 amRNSPinarova-1 Testing Operations Commence
12th Jan 20247:00 amRNSSuccessful Placing
11th Jan 20247:00 amRNSTurkey: Pinarova-1 Testing
10th Jan 202411:39 amRNSEquity Share Issue and Reduction in Loan Balance
9th Jan 20242:00 pmRNSCourt of Appeal Upholds Loxley Planning Consent
3rd Jan 20241:04 pmRNSTurkey: Pinarova-1 Operations Re-Commence
15th Dec 20237:00 amRNSTurkey: Pinarova-1 Testing Update
12th Dec 20237:00 amRNSHorse Hill Work Programme Extended by NSTA
11th Dec 20237:00 amRNSHorse Hill Farmin Update
8th Dec 20237:00 amRNSHorse Hill Developments Update
21st Nov 20237:00 amRNSTurkey: Pinarova-1 Testing Latest
3rd Nov 202312:13 pmRNSEquity Share Issue
13th Oct 20237:00 amRNSTurkey: Pinarova-1 Testing Update
22nd Sep 20237:00 amRNSTurkey: Pinarova-1 Testing Update
3rd Aug 20238:01 amRNSLoxley High Court Update
20th Jul 202310:44 amRNSHigh Court upholds Loxley Planning Consent
13th Jul 20237:00 amRNSAvington Oil Production to Restart
28th Jun 20237:00 amRNS£3 million funding facility
26th Jun 20232:13 pmRNSUnaudited results six-month ended 31 March 2023
21st Jun 20237:00 amRNSHorse Hill Update
8th Jun 20237:00 amRNSLoxley High Court hearing
23rd May 20239:06 amRNSTurkey: Pinarova-1 Testing Update
5th May 202312:12 pmRNSResult of Annual General Meeting
3rd May 20237:00 amRNSTurkey: Pinarova-1 Update
25th Apr 202312:30 pmRNSHolding(s) in Company
25th Apr 202312:13 pmRNSTurkey: Pinarova-1 drilling ahead
24th Apr 20237:00 amRNSHolding(s) in Company
21st Apr 20238:40 amRNSTurkey: Pinarova-1 oil shows & testing
18th Apr 202311:51 amRNSTurkey: Pinarova-1 casing set
13th Apr 202312:56 pmRNSHolding(s) in Company
13th Apr 20239:39 amRNSTurkey: Pinarova-1 reaches first casing point
11th Apr 20237:05 amRNSNotice of Annual General Meeting
11th Apr 20237:00 amRNSTurkey: Pinarova-1 drilling commences

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.